Literature DB >> 26977203

Perioperative chemotherapy for muscle-invasive bladder cancer: Closing the gap between evidence and practice.

Christopher M Booth1.   

Abstract

Entities:  

Year:  2016        PMID： 26977203      PMCID： PMC4771555          DOI： 10.5489/cuaj.3600

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  19 in total

Review 1.  Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.

Authors:  Jeffrey J Leow; William Martin-Doyle; Padma S Rajagopal; Chirayu G Patel; Erin M Anderson; Andrew T Rothman; Richard J Cote; Yuksel Urun; Steven L Chang; Toni K Choueiri; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2013-08-28       Impact factor: 20.096

Review 2.  Why is perioperative chemotherapy for bladder cancer underutilized?

Authors:  Francis M Patafio; William J Mackillop; Deb Feldman-Stewart; David Robert Siemens; Christopher M Booth
Journal:  Urol Oncol       Date:  2014-02-06       Impact factor: 3.498

3.  Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.

Authors:  C M Booth; D R Siemens; G Li; Y Peng; W Kong; D M Berman; W J Mackillop
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-06-20       Impact factor: 4.126

4.  Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

Authors:  Atreya Dash; Matthew D Galsky; Andrew J Vickers; Angel M Serio; Theresa M Koppie; Guido Dalbagni; Bernard H Bochner
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

5.  Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process.

Authors:  Jo-An Seah; Normand Blais; Scott North; Yasmin Rahim; Dean Ruether; Peter C Black; Alexandre R Zlotta; Lori Wood; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

6.  Processes of care and the impact of surgical volumes on cancer-specific survival: a population-based study in bladder cancer.

Authors:  D Robert Siemens; William J Mackillop; Yingwei Peng; David Berman; Ahmed Elharram; Jonathan Rhee; Christopher M Booth
Journal:  Urology       Date:  2014-10-24       Impact factor: 2.649

7.  Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.

Authors:  D Robert Siemens; William J Mackillop; Yingwei Peng; Xuejiao Wei; David Berman; Christopher M Booth
Journal:  Urol Oncol       Date:  2015-07-18       Impact factor: 3.498

Review 8.  Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Authors:  Cora N Sternberg; S Machele Donat; Joaquim Bellmunt; Randall E Millikan; Walter Stadler; Pieter De Mulder; Amir Sherif; Hans von der Maase; Taiji Tsukamoto; Mark S Soloway
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

9.  Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.

Authors:  Zachary D Reardon; Sanjay G Patel; Harras B Zaid; C J Stimson; Matthew J Resnick; Kirk A Keegan; Daniel A Barocas; Sam S Chang; Michael S Cookson
Journal:  Eur Urol       Date:  2014-01-23       Impact factor: 20.096

10.  Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.

Authors:  Christopher M Booth; D Robert Siemens; Gavin Li; Yingwei Peng; Ian F Tannock; Weidong Kong; David M Berman; William J Mackillop
Journal:  Cancer       Date:  2014-04-14       Impact factor: 6.860
View more
  1 in total

Review 1.  Advances in surgical management of muscle invasive bladder cancer.

Authors:  Janet Baack Kukreja; Jay B Shah
Journal:  Indian J Urol       Date:  2017 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.